Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Bone Marrow Diseases × Bone Marrow Examination × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Hematologic Diseases 1 Bone Marrow Diseases 1

Interventions

ruxolitinib 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 sonidegib 1 ponatinib 1 Quality of Life 1 Electrocardiography 1 Clinical Laboratory Techniques 1 CPI-0610 1 Bone Marrow Examination 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07387354 2026-03-16

MDS

Thomas Jefferson University

Phase 1/2 Not yet recruiting

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡